Federated Hermes, Inc. Dyne Therapeutics, Inc. Transaction History
Federated Hermes, Inc.
- $43 Billion
- Q4 2024
A detailed history of Federated Hermes, Inc. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,056,241 shares of DYN stock, worth $13.9 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,056,241
Previous 1,217,170
13.22%
Holding current value
$13.9 Million
Previous $43.7 Million
43.08%
% of portfolio
0.06%
Previous 0.1%
Shares
11 transactions
Others Institutions Holding DYN
# of Institutions
213Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$106 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$97.3 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$97.2 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$88.3 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$84 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $682M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...